IP Library Granted Patent US 9,301,988
Granted Patent B2
US 9,301,988 · App. 14/464,177 · Granted Apr 5, 2016

Method of treatment using a therapeutic agent for intranasal administration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,301,988
App. No.
14/464,177
Granted
Apr 5, 2016
Kind
B2
Abstract

A method of intranasal treatment of nasal symptoms administered to a human in need of the treatment includes administering intranasally from an internasal spray container a composition having a therapeutically effective amount of capsicum extract to a human in need thereof; and effecting relief from at least one symptom. The symptom relieved includes at least one of nasal congestion, sinus pressure, headache, sinus pain or a combination thereof. The first relief of sinus pain, sinus pressure, or nasal decongestion in the human occurs within about 30 minutes of administration.

Claims (3)

1. A method of intranasal treatment of nasal symptoms in a human in need thereof consisting essentially of the steps of:

(a) administering intranasally from an intranasal spray container a composition consisting essentially of a capsicum extract at a concentration of about 0.00060% to about 0.010% w/w, a rosemary extract at a concentration of about 0.02% to about 0.25% w/w, a eucalyptol extract at a concentration of about 0.07% to about 0.15% w/w, vegetable glycerin at a concentration of about 3.5% to about 5.0% w/w, ascorbic acid at a concentration of about 0.10% to about 0.90% w/w, sea salt at a concentration of about 0.40% to about 1.2% w/w, and potassium sorbate at a concentration of about 0.05% to about 0.3% to a human in need thereof; and

(b) wherein said administration provides relief to the human in need thereof from at least one symptom selected from the group consisting of nasal congestion, sinus pressure, headache, sinus pain and a combinations thereof.

Assignments (20)
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS @ REELS AND FRAMES: 053954/0755 AND 053955/0060 Recorded Jul 7, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS ADMINISTRATIVE AGENT
To: AKORN OPERATING COMPANY LLC
Reel/Frame 064234/0872 →
CORRECTION BY DECLARATION TO CORRECT THE 10 ERRONEOUSLY NULLIFIED PROPERTIES ON COVER SHEET AT REEL 057970 FRAME 0475. ASSIGNOR HEREBY CONFIRMS THAT THE 10 PROPERTIES LISTED THERE AND HEREIN SHOULD NOT HAVE BEEN NULLIFIED. Recorded Nov 12, 2021
From: AKORN OPERATING COMPANY LLC
To: MEDTECH PRODUCTS INC.
Reel/Frame 058104/0741 →
CORRECTION BY NULLIFICATION TO CORRECT INCORRECTLY RECORDED PROPERTY NUMBERS AT REEL/FRAME 57222/0489. ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 25, 2021
From: AKORN OPERATING COMPANY LLC
To: MEDTECH PRODUCTS INC.
Reel/Frame 057970/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2021
From: AKORN OPERATING COMPANY LLC
To: MEDTECH PRODUCTS INC.
Reel/Frame 057222/0489 →
RELEASE OF SECURITY INTEREST Recorded Jul 8, 2021
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: AKORN, INC.; AKORN INTERMEDIATE COMPANY LLC; AKORN OPERATING COMPANY, LLC
Reel/Frame 056794/0730 →
RELEASE OF SECURITY INTEREST Recorded Jul 8, 2021
From: MIDCAP FUNDING IV TRUST
To: AKORN OPERATING COMPANY, LLC
Reel/Frame 056794/0811 →
RELEASE OF SECURITY INTEREST RECORDED AT 032714/0418 Recorded May 10, 2021
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: HI-TECH PHARMACAL CO., INC.
Reel/Frame 056194/0802 →
- RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 048267/0252 Recorded Mar 29, 2021
From: JPMORGAN CHASE BANK, N.A.
To: HI-TECH PHARMACAL CO., INC.
Reel/Frame 055759/0564 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE OF PATENT APPLICATIONS AND GRANTED PATENTS TO BE ASSIGNED TO AKORN OPERATING COMPANY LLC PREVIOUSLY RECORDED ON REEL 054202 FRAME 0382. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 1, 2020
From: AKORN, INC.; ADVANCED VISION RESEARCH, LLC; HI-TECH PHARMACAL CO., LLC
To: AKORN OPERATING COMPANY, LLC
Reel/Frame 055326/0694 →
ENTITY CONVERSION Recorded Nov 24, 2020
From: HI-TECH PHARMACAL CO., INC.
To: HI-TECH PHARMACAL CO., LLC
Reel/Frame 054513/0466 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Nov 5, 2020
From: AKORN OPERATING COMPANY LLC
To: MIDCAP FUNDING IV TRUST
Reel/Frame 054333/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2020
From: AKORN, INC.; ADVANCED VISION RESEARCH, LLC; HI-TECH PHARMACAL CO., LLC
To: AKORN OPERATING COMPANY, LLC
Reel/Frame 054202/0382 →
SECURITY INTEREST Recorded Oct 1, 2020
From: AKORN OPERATING COMPANY LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 053955/0060 →
SECURITY INTEREST Recorded Oct 1, 2020
From: AKORN OPERATING COMPANY LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 053954/0755 →
SECURITY INTEREST Recorded May 26, 2020
From: HI-TECH PHARMACAL CO., INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 052753/0478 →
SECURITY INTEREST Recorded Apr 1, 2020
From: JPMORGAN CHASE BANK, N.A., AS RESIGNING ADMINISTRATIVE AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR ADMINISTRATIVE AGENT
Reel/Frame 052284/0386 →
SECURITY INTEREST Recorded Feb 7, 2019
From: HI-TECH PHARMACAL CO., INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 048267/0179 →
SECURITY INTEREST Recorded Feb 7, 2019
From: HI-TECH PHARMACAL CO., INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 048267/0252 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: DYNOVA LABORATORIES, INC.
To: HI-TECH PHARMACAL CO., INC.
Reel/Frame 037813/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2015
From: SICAP INDUSTRIES LLC
To: DYNOVA LABORATORIES, INC.
Reel/Frame 034863/0679 →